Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
AstraZeneca suffers cancer drug trial setback
Disappointing late-stage trial results for a closely watched lung cancer drug have dealt a blow to AstraZeneca. The FTSE 100 pharmaceuticals company expressed its confidence in datopotamab deruxtecan, or Dato-DXd, when it presented overall survival data for the treatment at…
English